Overall rank by patents
#648
of 49,997 tracked assignees
USPTO PatentsView assignee record - 690 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Immatics ranks #648 of 49,997 tracked US assignees by granted-patent volume, with 690 patents across 15 technology areas.
USPTO PatentsView assignee plate
Corpus R648 · Foreign Corporation #648 · 690 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Rivian IP Holdings, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Immatics Biotechnolo… · this assignee
51 score
Nile Global · near
51 score
Titan Medical · near
51 score
Parade · near
51 score
THE Board OF… · near
51 score
3D Lighting… · lowest
7 score
What this shows Immatics's Innovation Score is 51.0/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Immatics Biotechnologies GmbH is a focused PatentsView assignee: 15 CPC subclasses with 98.6% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (128 grants) versus a trough of 6 in 2016. By volume, Immatics sits between Cameron International Corporation and The Research Foundation for The State University of New York.
From 2019–2021 to 2022–2024, Immatics Biotechnologies GmbH moved from 367 to 194 grants (0.53x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,625. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cameron International Corporation
692 patents
Posco Co., Ltd
691 patents
Schneider Electric Industries SAS
691 patents
University of Washington
691 patents
Rivian IP Holdings, LLC
690 patents
Immatics Biotechnologies GmbH
690 patents
Carl Zeiss Meditec AG
689 patents
Saturn Licensing LLC
689 patents
The Research Foundation for The State University of New York
688 patents
What this shows Immatics holds 690 patents at rank #648, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #648 in granted patent volume.
Other assignees with the most granted patents in Immatics's primary technology class.
Two PlainPatent-derived peer sets for Immatics, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (51 here).
Nearest assignees by average claims per patent (18.8 here).
Immatics's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 8 | 1.2% |
| 2016 | 6 | 0.9% |
| 2017 | 7 | 1.0% |
| 2018 | 63 | 9.1% |
| 2019 | 115 | 16.7% |
| 2020 | 128 | 18.6% |
| 2021 | 124 | 18.0% |
| 2022 | 64 | 9.3% |
| 2023 | 51 | 7.4% |
| 2024 | 79 | 11.4% |
| 2025partial year | 45 | 6.5% |
Top 15 of 15 technology areas
Overall rank by patents
#648
of 49,997 tracked assignees
51.0 out of 100
What to do with this data
Immatics Biotechnologies GmbH's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.